News ArticleSterlite Technologies to Attend 29th CITIC CLSA India Forum and Host Plant Visit for Analysts in November 2026
Events scheduled for November 17 and 19, 2026, including a physical conference in Mumbai and a plant visit at Chhatrapati Sambhajinagar
Sterlite Technologies Limited announced its participation in the 29th CITIC CLSA India Forum 2026 on November 17 and a group plant visit at its Chhatrapati Sambhajinagar plants on November 19. Both events are organized by Credit Lyonnais Securities Asia and aim to engage with investors and analysts without sharing any unpublished price-sensitive information.
Sterlite Technologies Limited
Investor Presentation
Sterlite Technologies Limited will participate in the 29th CITIC CLSA India Forum on November 17, 2026, and conduct a plant visit for analysts and institutional investors on November 19, 2026, both events organized by Credit Lyonnais Securities Asia.
The company representatives will engage with investors and analysts during these events physically in Mumbai and at the company's Chhatrapati Sambhajinagar plants.
The company clarified that no unpublished price-sensitive information will be shared during the meetings.
The schedule is subject to changes due to organizer or company exigencies, and the meetings include both group and one-on-one sessions during business hours.
Highlights
- Participation in 29th CITIC CLSA India Forum on November 17, 2026, in Mumbai
- Group plant visit at Chhatrapati Sambhajinagar plants for analysts on November 19, 2026
- Meetings organized by Credit Lyonnais Securities Asia (CLSA)
- No unpublished price-sensitive information will be shared
- Schedule may change due to organizer or company requirements
Key Data Snapshot
What happened
- Sterlite Technologies Limited announced participation in the 29th CITIC CLSA India Forum 2026 on November 17, 2026.
- The company will host a group plant visit for analysts and institutional investors on November 19, 2026, at its Chhatrapati Sambhajinagar plants.
- Both events will be physical meetings held during business hours and organized by Credit Lyonnais Securities Asia (CLSA).
Key details
- The investor conference and plant visit are intended for group and one-on-one engagements with investors and analysts.
- Sterlite Technologies stated no unpublished price-sensitive information will be disclosed during these events.
- The schedule is subject to modifications depending on organizer or company circumstances.
Regulatory and governance context
- The disclosure is made under Regulation 30 of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
- All information to be shared will be from the public domain, keeping in line with regulatory requirements on price-sensitive information.
Highlights
- Participation in 29th CITIC CLSA India Forum on November 17, 2026, in Mumbai
- Group plant visit at Chhatrapati Sambhajinagar plants for analysts on November 19, 2026
- Meetings organized by Credit Lyonnais Securities Asia (CLSA)
- No unpublished price-sensitive information will be shared
- Schedule may change due to organizer or company requirements
Disclosures
- Regulation 30 of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
More News on Investor Presentation
View allLatest corporate announcements and market updates in Investor Presentation.
Rubicon Research Limited Reports Nearly 40% Revenue Growth and 68% Profit Increase in Q2 FY26-27
Rubicon Research Limited posted significant financial growth for the quarter ended September 30, 2026, with revenue increasing by 39.9% year-on-year to ₹5,764 million and profit after tax rising 67.9% to ₹904 million. This performance includes the consolidation impact of its recent Arinna acquisition and reflects strong operational cash flows and product approvals.
Read Full Story
Inventurus Knowledge Solutions Reports Q2 FY27 Investor Presentation Highlighting AI-Driven Growth and Platform Innovation
Inventurus Knowledge Solutions Limited disclosed its investor presentation for the quarter and half-year ended September 30, 2026, emphasizing advancements in its AI-powered healthcare enablement platform, strategic execution plans, and ongoing partnerships to drive growth and optimize margins.
Read Full Story
Sai Life Sciences Reports 23% Revenue Growth in Q2 FY27 with ₹659 Crore Revenue Amid Strategic Expansion
Sai Life Sciences Limited announced a 23% year-over-year revenue growth to ₹659 crore for the second quarter of fiscal year 2027, supported by healthy performance in both its Contract Research (CRO) and Contract Development and Manufacturing Organization (CDMO) segments. The company reported an EBITDA margin of 28% and continued its capital expenditure with ₹621 crore invested in the first half of FY27 to expand capacity and capabilities.
Read Full Story
